STUDY - Technical - New Dacian's Medicine

Endocrine
Diseases, Nutrition, and Metabolism
Translation Draft
A. Thyroid gland
disorders:
1. Congenital iodine
deficiency syndrome – includes endemic conditions associated
with iodine deficiency of the environment, either directly or as
a consequence of maternal iodine deficiency; some diseases do
not have a current hypothyroidism, but are the consequence of
abnormal secretion of thyroid hormone in the development of the
fetus; goiter due to the environment can be associated –
excludes hypothyroidism by subclinical deficiency in iodine
(congenital iodine deficiency syndrome of neurological type:
edemaic cretinism of neurological type; Congenital deficiency
syndrome of iodine of myxedematos type – endemic cretinism:
hypothyroid, myxedematic type; Congenital deficiency syndrome of
iodine of mixed type: endemic cretinism of mixed type;
Congenital deficiency syndrome of unspecified iodine:
hypothyroidism by congenital deficiency of nos iodine, nos
endemic cretinism);
2. Thyroid disorders and
related diseases related to iodine deficiency – exclude
congenital iodine deficiency syndrome, hypothyroidism by
subclinical iodine deficiency (Diffuse (endemic) goiter related
to iodine deficiency; Multiinodular (endemic) goiter related to
an iodine deficiency: nodular goiter related to iodine
deficiency; Goiter (endemic) related to the unspecified iodine
deficiency: NOS endemic goiter; Other thyroid and related
disorders related to iodine deficiency: hypothyroidism due to
nos acquired iodine deficiency);
3. Hypothyroidism by
subclinical deficiency of iodine;
4. Other hypothyroidisms –
exclude hypothyroidism related to an iodine deficiency,
postprocedural hypothyroidism (Congenital hypothyroidism with
diffuse goiter: goiter (nontoxic) congenital nos, parenchymal –
excludes transient congenital goiter with normal function;
Congenital hypothyroidism without goiter: Thyroid aplasia (with
myxedema), congenital: thyroid atrophy, NOS hypothyroidism;
Hypothyroidism due to some drugs and other exogenous substances;
Post-infectious hypothyroidism; Thyroid atrophy (acquired) –
excludes congenital atrophy of the thyroid; Myxedematic coma;
Other hypothyroidisms specified; Unspecified hypothyroidism:
MYXED NOS);
5. Other non-toxic goiter
– excludes diffuse congenital goiter, NOS, parenchymal, goiter
related to an iodine deficiency (Non-toxic diffuse goiter –
non-toxic goiter: diffuse (colloidal), simple; Unique non-toxic
thyroid nodule: colloid (cystic) nodule (thyroid), non-toxic
uninodular goiter, thyroid (cystic) nos nodule; Non-toxic
multinodular goiter: NOS cystic goiter, nos multinodular
(cystic) goiter; Other non-toxic goiter specified, Non-toxic
goiter not specified: NOS goiter, nodular (nontoxic) GOIter
NOS);
6. Thyrotoxicosis
(hyperthyroidism) – excludes chronic thyroiditis with transient
thyrotoxicosis, neonatal thyrotoxicosis (Thyrotoxicosis with
diffuse goiter: exophthalmic or nos toxic goiter, Graves
disease, diffuse toxic goiter; Thyrotoxicosis with single
thyroid node: thyrotoxicosis with toxic uninodular goiter;
Thyrotoxicosis with toxic multinodular goiter: NOS toxic nodular
goiter; Thyrotoxicosis due to thyroid ectopic tissue; Factic
thyrotoxicosis; Acute thyrotoxic crisis; Other thyrotoxicosis:
overproduction of thyroid-stimulating hormone; Unspecified
thyrotoxicosis: NOS hyperthyroidism, thyrotoxic heart disease);
7. Thyroiditis – excludes
postpartum thyroiditis (Acute thyroiditis: abscess of the
thyroid – thyroiditis: pyogenous, suppurated; Subacute
thyroiditis – thyroiditis: de Quervain, gigantic cells,
granulomatous, nonsuppressive – exclude autoimmune thyroiditis;
Chronic thyroiditis with transient thyrotoxicosis – excludes
autoimmune thyroiditis; Autoimmune thyroiditis: Hashimoto's
thyroiditis, Hashitoxicosis (transient), Lymphadenoid goiter,
Lymphocytic thyroiditis, Lymphomatous strumitis; Thyroiditis
caused by medications; Other chronic thyroiditis – thyroiditis:
chronic fibrous, NOS, woody, Riedel; Unspecified thyroiditis);
8. Other thyroid disorders
(Calcitonin hypersecretion: C-cell hyperplasia of the thyroid,
hypersecretion of thyrocalcitonin; Goiter due to a disorder of
hormonal synthesis: familial goiter due to a hormonal synthesis
disorder, Pendred syndrome – excludes transient congenital
goiter with normal function; Other specified diseases of
toroidism: thyroglobulin anomaly, thyroid hemorrhage, thyroid
infarction, euthyroid dysfunction syndrome; Unspecified thyroid
disease);
B. Regulation of glucose
intolerance and mellitus diabetes.
– according to who
criteria for regulating glucose intolerance (revised in 1999),
the tolerance test based on the correct administration of
glucose orally (venously harvested plasma glucose on the uneaten
is 6.1 – 6.9 mmol/ l or venous plasma glucose 2 hours after oral
glucose administration is 7.8 – 11 mmol/ l or the level of
venous plasma glucose on uneaten 6.1 – 6.9 mmol/ l; criteria for
diabetes mellitus: tolerance test based on the correct
administration of glucose orally (uneaten venously harvested
plasma glucose greater than or equal to 7 mmol/l or venous
plasma glucose 2 hours after oral glucose administration, venous
plasma glucose 2 hours after administration of oral glucose
greater than or equal to 11.1 mmol/ l) or the level of uneaten
venous plasma glucose higher than 7 mmol/ l or classical
symptoms of thirst, polyuria and randomized venous plasma
glucose greater than 11.1 mmol/ l):
1. Regulation of glucose
intolerance – includes abnormal glucose (carbohydrates),
regulation, tolerance, chemical diabetes, latent diabetes,
intolerance: low blood glucose levels (IFG), low glucose
(carbohydrates) (IGT), prediabetes and excludes diabetes
mellitus, high blood glucose levels (Regulation of glucose
intolerance with peripheral angiopathy (Regulation of glucose
intolerance with peripheral angiopathy (Regulation of glucose
intolerance with peripheral angiopathy; Regulation of glucose
intolerance with peripheral angiopathy with gangrene; Regulation
of glucose intolerance with characteristics of insulin
resistance – regulation of glucose intolerance with:
Hypertension with any condition below and / or obesity NOS,
Increased visceral fat deposit, Insulin resistance NOS, One or
more of the following: achantosis nigricans, dyslipidemia,
hyperinsulinism, obesity; Regulating glucose intolerance with
unspecified complications; Regulating glucose intolerance
without complications);
2. Diabet mellitus type 1
– includes autoimmune, fragile, idiopathic, insulin-dependent
diabetes (mellitus), with onset in young people, prone to
ketosis and excludes diabetes mellitus due to/ in neonatal, NOS,
other specified forms, pregnancy, childbirth, lausia, type 2,
glycosuria: NOS, renal, regulation of glucose intolerance,
postprocedural hypoinsulinemia (Diabetes mellitus type 1 with
acidosis, Diabetes mellitus type 1 with acidocetosis without
coma: diabet mellitus type 1 with acidocetosis NOS, Diabet
mellitus type 1 with acidocetosis with coma: diabet mellitus
type 1 with hyperglycemic coma NOS, Diabet mellitus type 1 with
lactic acidosis without coma: diabetes mellitus type 1 with
lactic acidosis NOS, Diabetes mellitus type 1 with lactic
acidosis with coma, Diabet mellitus type 1 with acidocetosis
with lactic acidosis without coma: diabetes mellitus type 1 with
acidocetosis with lactic acidosis NOS, Diabetes mellitus type 1
with acidocetosis with lactic acidosis with coma; Diabetes
mellitus type 1 with renal complications: Diabetes mellitus type
1 with incipient diabetic nephropathy – diabetes mellitus type 1
with glomerular thickened basal membrane, mezzangial expansion,
incipient (early) nephropathy (reversible), constant, persistent
microalbuminuria; Diabetes mellitus type 1 with established
diabetic nephropathy – diabetes mellitus type 1 with diffuse
glomerulosclerosis, intracapillary, nodular; Kimmelstiel-Wilson
(disease) (lesion), macroalbuminuria, nephropathy (advanced)
(NOS) (progressive), proteinuria (fixed) (persistent), Diabetes
mellitus type 1 with end-stage kidney disease (ESRD): diabetes
mellitus type 1 with chronic renal failure or chronic kidney
injury; Diabetes mellitus type 1 with eye complications;
Diabetes mellitus type 1 with background retinopathy – diabetes
mellitus type 1 with: retinal(a), hemorrhage (with points and
spots) (in the form of flame), exudate, microaneurysm, venous
dilation, NOS retinopathy; Diabetes mellitus type 1 with
preproliferative retinopathy: diabetes mellitus type 1 with:
intraretinal microvascular abnormalities (IRMA), retinal: spots
in a vătous form, hemorrhages (with spots) (round) (small),
ischemia, venous (oss): pearl, curly, doubled; Diabetes mellitus
type 1 with proliferative retinopathy – diabetes mellitus type 1
with: preretinal hemorrhage, glassy, formation of new vessel
(neovascularization), retinal traction without detachment;
Diabetes mellitus type 1 with other retinopathies – diabetes
mellitus type 1 with: macular, edema (focal) (generalized)
(intraretinal), in the form of a star, maculopathy (circinate)
(ischemic), retinal thickening; Diabetes mellitus type 1 with
diabetic cataract – excludes diabetes mellitus type 1 with
cataracts with onset at early age; Diabetes mellitus type 1 with
other specified eye complications: diabetes mellitus type 1 with
cataracts with onset at early age; Diabetes mellitus type 1 with
cataracts with neurological complications; Diabetes mellitus
type 1 with unspecified neuropathy; Diabetes mellitus type 1
with diabetic mononeuropathy – diabetes mellitus type 1 with
amyotrophy, cranial nerve palsy III (oculomotor), VI (abductor),
femoral neuropathy, multiple mononeurisitis, ophthalmoplegia,
radiculopathy: thoracic, troncular; Diabetes mellitus type 1
with diabetic polyneuropathy – diabetes mellitus type 1 with
insulin neurititis, symmetrical distal peripheral neuropathy,
selective "with small fibers", sensorsomotory – excludes
diabetes mellitus type 1 with autonomous diabetic
polyneuropathy; Diabetes mellitus type 1 with autonomic diabetic
neuropathy – diabetes mellitus type 1 with: abnormal secretion
(gustatory), autonomic diabetic polyneuropathy, diabetic
diarrhea, anorectal dysfunction, esophageal, gastroparesis,
hypotonia of the bladder, neuropathic edema, postural
hypotension; Diabetes mellitus type 1 with other specified
neurological complications; Diabetes mellitus type 1 with
peripheral angiopathy without gangrene – excludes diabetes
mellitus type 1 with peripheral angiopathy without foot
ulceration; Diabetes mellitus type 1 with peripheral angiopathy
with gangrene – excludes diabetes mellitus type 1 with
peripheral angiopathy with gangrene with leg ulceration;
Diabetes mellitus type 1 with diabetic ischemic cardiomyopathy;
Diabetes mellitus type 1 with other specified complications;
Diabetes mellitus type 1 with specified musculoskeletal and
connective tissue diabetic complications – diabetes mellitus
type 1 with Charcot arthropathy, diabetic/s hand syndrome
(cheiroararthropathy) (Dupuytren's contracture) (palmar fascial
fibromatosis), osteopathy, shoulder periarthritis; Diabetes
mellitus type 1 with complications of the skin and subcutaneous
tissue specified – diabetes mellitus type 1 with diabetic(a)
bullous (bullosis diabeticorum), dermopathy (skin spots),
erythema, rubella, scleroderma, skin thickening, diabetic
lipoidic necrobiosis (NLD), periunghial telangiectasia; Diabetes
mellitus type 1 with specified periodontal complications –
diabetes mellitus type 1 with acute periodontal abscess,
periodontitis; Diabetes mellitus type 1 with hypoglycemia –
diabetes mellitus type 1 with hypoglycemia(ic) coma, NOS, attack
(seizures) (seizure); Diabetes mellitus type 1 with poor control
– diabetes mellitus type 1 for stabilization, poorly controlled,
unstable; Diabetes mellitus type 1 with other specified
complications – diabetes mellitus type 1 with gangrene (acute
dermal) (bacterial) (hemolytic), Forunier, Meleney, necrotizing
fascita, ulcer (lower extremities) – excludes foot ulceration on
the periphery with angiopathy and / or neuropathy; Diabetes
mellitus type 1 with multiple complications; Diabetes mellitus
type 1 with multiple microvascular complications; Diabetes
mellitus type 1 with leg ulceration due to multiple causes –
diabetes mellitus type 1 with foot ulceration on the periphery
with angiopathy and / or neuropathy; Diabetes mellitus type 1
with unspecified complications, Diabetes mellitus type 1 without
complications);
3. Diabet mellitus type 2
– includes diabetes (mellitus) (without obesity) (obesity),
onset in adults, due to a defect in insulin secretion, insulin
resistant, mature onset, noncetonic and excludes diabetes
mellitus (in) NOS glycosuria, renal, mature onset (in young
people) (MODY), neonatal, NOS, other specified forms, pregnancy,
birth, lausia, type 1, Regulation of glucose intolerance,
postprocedural hypoinsulinemia (Diabetes mellitus type 2 with
hyperosmolarity; Diabetes mellitus type 2 with hyperosmolarity
without hypercytic hyperglycemic-hyperosmolar noncetotic coma
(NKHHC), mellitus type 2 diabetes with NOS hyperosmolarity;
Diabetes mellitus type 2 with hyperosmolarity with coma;
Diabetes mellitus type 2 with acidosis; Diabetes mellitus type 2
with comaless acidocetosis – diabetes mellitus type 2 with NOS
acidocetosis; Diabetes mellitus type 2 with coma acidocetosis –
diabetes mellitus type 2 with hyperglycemic coma NOS; Diabetes
mellitus type 2 with lactic acidosis without coma – diabetes
mellitus type 2 with nos lactic acidosis; Diabetes mellitus type
2 with lactic acidosis with coma; Diabetes mellitus type 2 with
lactic acidocetosis without coma – diabetes mellitus type 2 with
acidocetosis with nos lactic acidosis; Diabetes mellitus type 2
with acidocetosis with lactic acidosis with coma; Diabetes
mellitus type 2 with kidney complications; Diabetes mellitus
type 2 with incipient diabetic nephropathy – diabetes mellitus
type 2 with thickened glomerular membrane, mezzangial expansion,
incipient (early) nephropathy (reversible), constant, persistent
microalbuminuria; Diabetes mellitus type 2 with diffuse
glomerulosclerosis, intracapillary, nodular, Kimmelstiel-Wilson
(disease) (lesion), macroalbuminuria, nephropathy (advanced)
(NOS) (progressive), proteinuria (fixed) (persistent); Diabetes
mellitus type 2 with end-stage kidney disease (ESRD) – diabetes
mellitus type 2 with chronic renal failure or chronic kidney
injury; Diabetes mellitus type 2 with other specified renal
complications – diabetes mellitus type 2 with acute renal
failure, medullary necrosis (papillary); Diabetes mellitus type
2 with eye complications; Diabetes mellitus type 2 with
background retinopathy – diabetes mellitus type 2 with retinal
hemorrhage (with points and spots) (in the form of flame),
exudate, microaneurysm, venous dilatation, NOS retinopathy;
Diabet mellitus type 2 with preproliferative retinopathy –
diabetes mellitus type 2 with intratinal microvascular
abnormalities (IRMA), retinal spots in injurious form,
hemorrhages (with spots) (round) (small), ischemia, venous
(oss), pearly, curly, doubled; Diabetes mellitus type 2 with
proliferative retinopathy – diabetes mellitus type 2 with
preretinal, vitreous hemorrhage, formation of new vessel
(neovascularization), retinal traction without detachment;
Diabetes mellitus type 2 with other retinopathies – diabetes
mellitus type 2 with macular, edema (focal) (generalized)
(intraretinal) (intraretinal), star form, maculopathy
(circinate) (ischemic), retinal thickening); Diabetes mellitus
type 2 with advanced eye disease – diabetes mellitus type 2 with
neovascular glaucoma, iris rubella (rubeosis iridis), detached
retinal traction; Diabetes mellitus type 2 with diabetic
cataract – excludes diabetes mellitus type 2 with cataracts with
onset at early age; Diabetes mellitus type 2 with other
specified eye complications – diabetes mellitus type 2 with
cataracts with onset in early age; Diabetes mellitus type 2 with
neurological complications; Diabetes mellitus type 2 with
unspecified neuropathy; Diabetes mellitus type 2 with diabetic
mononeuropathy – diabetes mellitus type 2 with amyotrophy,
cranial nerve palsy III (oculomotor), VI (abductor), femoral
neuropathy, multiple mononeuriitis, ophthalmoplegia, thoracic
radiculopathy, troncular; Diabetes mellitus type 2 with diabetic
polyneuropathy – diabetes mellitus type 2 with insulin neuritus,
symmetrical distal peripheral neuropathy, selective "with small
fibers", sensorinemotory – excludes diabetes mellitus type 2
with autonomic diabetic polyneuropathy; Diabetes mellitus type 2
with autonomic diabetic neuropathy – diabetes mellitus type 2
with abnormal secretion (gustatory), autonomic diabetic
polyneuropathy, diabetic diarrhea, anorectal dysfunction,
esophageal, erectile failure (impotence), gastroparesis,
hypotonia of the bladder, neuropathic edema, postural
hypotension; Diabetes mellitus type 2 with other neurological
complications specified; Diabetes mellitus type 2 with
circulatory complications; Diabetes mellitus type 2 with
peripheral angiopathy without gangrene – excludes diabetes
mellitus type 2 with peripheral angiopathy without leg
ulceration; Diabetes mellitus type 2 with peripheral angiopathy
with gangrene – excludes diabetes mellitus type 2 with
peripheral angiopathy with gangrene with foot ulceration;
Diabetes mellitus type 2 with diabetic ischemic cardiomyopathy;
Diabetes mellitus type 2 with other specified complications;
Diabetes mellitus type 2 with other diabetic musculoskeletal and
connective tissue complications specified – diabetes mellitus
type 2 with Charcot arthropathy, diabetic hand syndrome
(cheiroartropathy) (Dupuytren's contracture) (palmar facial
fibromatosis), osteopathy, shoulder periarthritis; Diabetes
mellitus type 2 with complications of the skin and subcutaneous
tissue specified – diabetes mellitus type 2 with diabetic:
bullous (bullosis diabeticorum), dermopathy (skin spots),
erythema, rubella, scleroderma, thickening of the skin, diabetic
lipoidic necrobiosis (NLD), periunghial telangiectasia; Diabetes
mellitus type 2 with specified periodontal complications –
mellitus type 2 diabetes with acute periodontal abscess,
periodontitis; Diabetes mellitus type 2 with hypoglycemia –
diabetes mellitus type 2 with hypoglycemia coma, NOS, attack
(seizures) (crisis); Diabetes mellitus type 2 with poor control
– diabetes mellitus type 2 for stabilization, poorly controlled,
unstable, Diabet mellitus type 2 with other specified
complications – diabetes mellitus type 2 with gangrene (acute
dermal) (bacterial) (hemolytic), Fournier, Meleney, necrotizing
fasciitis, ulcer (lower extremities) – excludes foot ulceration
on the periphery with angiopathy, neuropathy; Diabetes mellitus
type 2 with multiple complications; Diabetes mellitus type 2
with multiple microvascular complications (two or more);
Diabetes mellitus type 2 with characteristics of insulin
resistance – diabetes mellitus type 2 with hypertension with any
related condition shown below, NOS obesity, increased visceral
fat deposit, insulin resistance NOS, one or more of the
following: achantosis nigricans, dyslipidemia, hyperinsulinism,
obesity; Diabetes mellitus type 2 with ulceration of the foot
and periphery with angiopathy, neuropathy; Diabetes mellitus
type 2 with unspecified complications; Diabetes mellitus type 2
without complications);
4. Other specified forms
of diabetes mellitus – include diabetes mellitus (due to)
(secondary) (in) (with) drug-induced or chemically induced,
endocrinopathy, genetic defect of beta cell functioning, insulin
action, genetic syndrome, immuno-mediated disease, infection,
mature onset in young people (MODY), exocrine pancreatic disease
and excludes diabetes mellitus (in) neonatal diabetes, NOS,
pregnancy, birth, lausia, type 1, type 2, GLYCOSURIA NOS, renal,
regulation of glucose intolerance (Other specified forms of
diabetes mellitus with hyperosmolarity; Other specified forms of
diabetes mellitus with hyperosmolarity without
hyperglycemic-hyperosmolar noncetotic coma (NKHHC) – diabetes
mellitus NEC with nos hyperosmolarity; Other specified forms of
diabetes mellitus with hyperosmolarity with coma; Other forms of
diabetes mellitus with acidosis; Other specified forms of
diabetes mellitus with coma-free acidocetosis – diabet mellitus
NEC with NOS acidocetosis; Other specified forms of diabetes
mellitus with coma acidocetosis – diabet mellitus NEC with
hyperglycemic coma NOS; Other specified forms of diabetes
mellitus with coma-free lactic acidosis – diabet mellitus NEC
with nos lactic acidosis; Other specified forms of diabetes
mellitus with coma lactic acidosis; Other specified forms of
diabetes mellitus with kidney complications; Other specified
forms of diabetes mellitus with incipient diabetic nephropathy –
diabet mellitus NEC with thickened glomerular membrane,
mezzangial expansion, incipient (early) nephropathy
(reversible), constant, persistent microalbuminuria; Other
specified forms of diabetes mellitus with established diabetic
nephropathy – diabetes mellitus NEC with diffuse
glomerulosclerosis, intracapillary, nodular, Kimmelstiel-Wilson
(disease) (lesion), macroalbuminuria, nephropathy (advanced)
(NOS) (progressive), proteinuria (fixed) (persistent); Other
specified forms of diabetes mellitus with end-stage kidney
disease (ESRD) – diabetes mellitus type 2 with chronic renal
failure or chronic kidney injury; Other specified forms of
diabetes mellitus with other specified renal complications –
diabetes mellitus NEC with acute renal failure, medullary
necrosis (papillary); Other specified forms of diabetes mellitus
with ocular complications; Other specified forms of diabetes
mellitus with background retinopathy – diabet mellitus NEC with
retinal hemorrhage (with points and spots) (in the form of
flame), exudate, microaneurysm, venous dilation, NOS
retinopathy; Other forms of diabetes mellitus with
preproliferative retinopathy – diabet mellitus NEC with
intratinal microvascular abnormalities (IRMA), retinal spots in
inadulging form, hemorrhages (with spots) (round) (small),
ischemia, venous (s) pearly, curly, doubled; Other specified
forms of diabetes mellitus with proliferative retinopathy –
diabetes mellitus NEC with hemorrhage, preretinal, vitreous,
formation of new vessel (neovascularization), retinal traction
without detachment; Other specified forms of diabetes mellitus
with other retinopathies – diabet mellitus NEC with macular
edema (focal) (generalized) (intraretinal), in the form of a
star, maculopathy (circinate) (ischemic), retinal thickening;
Other specified forms of diabetes mellitus with advanced eye
disease – diabet mellitus NEC with neovascular glaucoma, iris
rubella (rubeosis iridis), detached retinal traction; Other
specified forms of diabetes mellitus with diabetic cataract –
excludes diabetes mellitus NEC with cataracts with onset early
age; Other specified forms of diabetes mellitus with other
specified eye complications – diabetes mellitus NEC with
cataracts with onset at early age; Other specified forms of
diabetes mellitus with neurological complications; Other
specified forms of diabetes mellitus with unspecified
neuropathy; Other specified forms of diabetes mellitus with
diabetic mononeuropathy – diabet mellitus NEC with amyotrophy,
cranial nerve palsy III (oculomotor), VI (abductor), femoral
neuropathy, multiple mononeurisitis, ophthalmoplegia, thoracic
radiculopathy, troncular; Other specified forms of diabetes
mellitus with diabetic polyneuropathy – diabet mellitus NEC with
insulin neurit, symmetrical distal peripheral neuropathy,
selective "small fiber", sensorimotor – exclude diabetes
mellitus with autonomous diabetic polyneuropathy; Other
specified forms of diabetes mellitus with autonomic diabetic
neuropathy – diabetes mellitus NEC with abnormal (gustatory)
sweating, autonomic diabetic polyneuropathy, diabetic diarrhea,
anorectal dysfunction, esophageal, erectile failure (impotence),
gastroparesis, hypotonia of the bladder, neuropathic edema,
postural hypotension; Other specified forms of diabetes mellitus
with other specified neurological complications; Other specified
forms of diabetes mellitus with circulatory complications; Other
specified forms of diabetes mellitus with peripheral angiopathy
without gangrene – excludes diabetes mellitus NEC with
peripheral angiopathy with foot ulceration; Other specified
forms of diabetes mellitus with peripheral angiopathy with
gangrene – excludes diabetes mellitus NEC with peripheral
angiopathy with gangrene with foot ulceration; Other specified
forms of diabetes mellitus with diabetic ischemic heart disease;
Other specified forms of diabetes mellitus with other specified
complications; Other specified forms of diabetes mellitus with
specified musculoskeletal and connective tissue diabetic
complications – diabetes mellitus NEC with Charcot arthropathy,
diabetic hand syndrome (cheiroartropathy) (Dupuytren's
contracture) (palmar fascial fibromatosis), osteopathy, shoulder
periarthritis; Other specified forms of diabetes mellitus with
complications of the skin and subcutaneous tissue specified –
diabetes mellitus NEC with diabetic(a) bullous (bullosis
diabeticorum), dermopathy (skin spots), erythema, rubella,
scleroderma, skin thickening, diabetic lipoidic necrobiosis
(NLD), periunghial telangiectasia; Other specified forms of
diabetes mellitus with specified periodontal complications –
diabetes mellitus NEC with acute periodontal abscess,
periodontitis; Other specified forms of diabetes mellitus with
hypoglycemia – diabetes mellitus NEC with hypoglycemia coma,
NOS, attack (seizures) (crisis); Other specified forms of
diabetes mellitus with contro, weak – other specified forms of
diabetes mellitus for stabilization, poorly controlled,
unstable, with secondary treatment failure; Other specified
forms of diabetes mellitus with other specified complications –
diabetes mellitus NEC with gangrene (acute dermal) (bacterial)
(hemolytic) Fournier, Meleney, necrotizing fasciitis, ulcer
(lower extremities) – excludes foot ulceration on the periphery
with angiopathy, neuropathy; Other specified forms of diabetes
mellitus with multiple complications; Other specified forms of
diabetes mellitus with multiple microvascular complications –
two or more conditions; Other specified forms of diabetes
mellitus with characteristics of insulin resistance – other
specified forms of diabetes mellitus with hypertension with any
condition below: NOS obesity, increased visceral fat deposit,
nos insulin resistance, one or more of the following achantosis
nigricans, dyslipidemia, hyperinsulinism, obesity; Other
specified forms of diabetes mellitus with leg ulceration due to
multiple causes – diabetes mellitus NEC with foot ulceration on
the periphery with angiopathy and / or neuropathy; Other
specified forms of diabetes mellitus with unspecified
complications; Other specified forms of diabetes mellitus
without complications);
5. Unspecified diabetes
mellitus – diabet mellitus NOS – excludes diabet mellitus (in)
neonatal, non-insulin dependent, pregnancy, birth, lausia, type
1, type 2, NOS glycosuria, renal, regulation of glucose
intolerance, postprocedural hypoinsulinemia (Diabetes mellitus
not specified with hyperosmolarity; Diabetes mellitus
unspecified with hyperosmolarity without
hyperglycemic-hyperosmolar noncetotic coma (NKHHC) – diabetes
mellitus NOS with nos hyperosmolarity; Unspecified mellitus
diabetes mellitus with hyperosmolarity with coma; Diabetes
mellitus unspecified with acidosis; Diabetes mellitus not
specified with coma-free acidocetosis – diabet mellitus NOS with
nos acidocetosis; Diabetes mellitus unspecified with coma
acidocetosis – diabet mellitus NOS with hyperglycemic coma NOS;
Diabetes mellitus unspecified with lactic acidosis without coma
– diabet mellitus NOS with nos lactic acidosis; Diabetes
mellitus unspecified with lactic acidosis with coma; Diabetes
mellitus not specified with coma-free lactic acidic acidosis
with lactic acidosis – diabet mellitus NOS with lactic
acidocetosis NOS; Diabetes mellitus not specified with
acidocetosis with lactic acidosis c coma; Diabetes mellitus
unspecified with kidney complications; Diabetes mellitus
unspecified with incipient diabetic nephropathy – diabet
mellitus NOS with thickened glomerular membrane, mezzangial
expansion, incipient (early) nephropathy (reversible), constant,
persistent microalbuminuria; Diabetes mellitus unspecified with
established diabetic nephropathy – diabetes mellitus NOS with
diffuse glomerulonecrosis, intracapillary, nodular,
Kimmelstiel-Wilson (disease) (lesion), macroalbuminuria,
nephropathy (advanced) (NOS) (progressive), proteinuria (fixed)
(persistent); Diabetes mellitus unspecified with end-stage
kidney disease (ESRD) – diabetes mellitus NOS with chronic renal
failure; Diabetes mellitus unspecified with other specified
renal complications – diabetes mellitus NOS with acute renal
failure, medullary necrosis (papillary); Diabetes mellitus
unspecified with eye complications; Diabetes mellitus
unspecified with background retinopathy – diabet mellitus NOS
with retinal hemorrhage (with points and spots) (in the form of
flame), exudate, microaneurysm, venous dilation, NOS
retinopathy; Diabetes mellitus not specified with
preproliferative retinopathy – diabet mellitus NOS with
intratinal microvascular abnormalities (IRMA) retinal spots in a
vătous form, hemorrhages (with spots) (round) (small), ischemia,
venous (os) pearly, curly, doubled; Diabetes mellitus
unspecified with proliferative retinopathy – diabet mellitus NOS
with preretinal, vitreous hemorrhage, formation of new vessel
(neovascularization), retinal traction without detachment;
Diabetes mellitus unspecified with other retinopathies –
diabetes mellitus NOS with macular, edema (focal) (generalized)
(intraretinal), star form, maculopathy (circinate) )ischemic),
retinal thickening; Diabetes mellitus unspecified with advanced
eye disease – diabetes mellitus NOS with neovascular glaucoma,
iris rubella (rubeosis iridis), detached retinal traction;
Diabetes mellitus unspecified with diabetic cataract – excludes
diabetes mellitus NOS with cataracts with onset at early age;
Diabetes mellitus unspecified with neurological complications;
Diabetes mellitus unspecified with unspecified neuropathy ̧
Diabetes mellitus not specified with diabetic mononeuropathy –
diabetes mellitus NOS with amyotrophy, cranial nerve palsy III
(oculomotor), VI (abductor), femoral neuropathy, multiple
mononeurisitis, ophthalmoplegia, thoracic radiculopathy,
troncular; Diabetes mellitus unspecified with diabetic
polyneuropathy – diabetes mellitus NOS with insulin neurit,
distal peripheral neuropathy, selective "small fiber",
sensorimotor – excludes diabetes mellitus NOS with autonomic
diabetic polyneuropathy; Diabetes mellitus unspecified with
autonomic diabetic neuropathy – diabetes mellitus NOS with
abnormal sweating (gustatory), autonomic diabetic
polyneuropathy, diabetic diarrhea, anorectal dysfunction,
esophageal, erectile failure (impotence), gastroparesis,
hypotonia of the bladder, neuropathic edema, postural
hypotension; Diabetes mellitus unspecified with other specified
neurological complications; Diabetes mellitus unspecified with
circulatory complications; Diabetes mellitus unspecified with
peripheral angiopathy without gangrene – excludes diabetes
mellitus NOS with peripheral angiopathy with leg ulceration;
Diabetes mellitus unspecified with peripheral angiopathy with
gangrene – excludes diabetes mellitus NOS with peripheral
angiopathy with gangrene with foot ulceration; Diabetes mellitus
unspecified with diabetic ischemic cardiomyopathy; Diabetes
mellitus unspecified with other specified complications;
Diabetes mellitus unspecified with diabetic complications
musculoskeletal and connective tissue specified – diabetes
mellitus NOS with Arthropathy Charcot, diabetic hand syndrome
(cheiroartropathy) (Dupuytren's contracture) (palmar fascial
fibromatosis), osteopathy, shoulder periarthritis; Diabetes
mellitus unspecified with complications of the skin and
subcutaneous tissue specified – diabetes mellitus NOS with
diabetic(a) bullous (bullosis diabeticorum), dermopathy (skin
spots), erythema, rubella, scleroderma, skin thickening,
diabetic lipoidic necrobiosis (NLD), periunghial telangiectasia;
Diabetes mellitus unspecified with specified periodontal
complications – diabetes mellitus NOS with acute periodontal
abscess, periodontitis; Diabetes mellitus unspecified with
hypoglycemia – diabetes mellitus NOS with hypoglycemia, coma,
NOS, attack (seizures) (crisis); Diabetes mellitus unspecified
with poor control – diabetes mellitus unspecified for
stabilization, controlled weak, unstable, with the failure of
secondary treatment; Diabetes mellitus unspecified with other
specific complications – diabet mellitus NOS with gangrene
(acute dermal) (bacterial) (hemolytic), Fournier, Meleney,
necrotizing fasciitis, ulcer (lower extremities) – excludes foot
ulceration on the periphery with angiopathy, neuropathy;
Diabetes mellitus unspecified with multiple complications;
Unspecified diabetes mellitus with multiple microvascular
complications – two or more conditions; Diabetes mellitus
unspecified with characteristics of insulin resistance –
diabetes mellitus unspecified with hypertension with any
condition below, nos obesity, increased visceral fat depot,
insulin resistance NOS, one or more of the following: achantosis
nigricans, dyslipidemia, hyperinsulinism, obesity; Diabetes
mellitus unspecified with leg ulceration due to multiple causes
– diabetes mellitus NOS with ulceration of the foot and
periphery: angiopathy, neuropathy; Diabetes mellitus unspecified
with unspecified complications; Unspecified mellitus diabetes
without complications);
C. Other disorders of
glucose metabolism and internal pancreatic secretion:
1. Nondiabetic
hypoglycemic coma (Drug-induced insulin coma in nondiabetics;
Hyperinsulinism with hypoglycemic coma; Hypoglycemic COMA NOS);
2. Other disorders of
pancreatic internal secretion (drug-induced hypoglycemia without
coma; Other hypoglycemia: Functional nonhyperinsulemic
hypoglycemia; Hyperinsulinism: functional, NOS; Hyperplasia of
beta cells of pancreatic islets NOS; Encephalopathy due to
postglycemic coma; Unspecified hypoglycemia; Glucagon
hypersecretion: hyperplasia of pancreatic endocrine cells with
excess glucagon; Abnormal secretion of gastrin: hypergastremia,
Zollinger-Ellison syndrome; Other specified disorders of
pancreatic internal secretion: endocrine hypersecretion of the
pancreas by growth hormone profactor (GHRH), pancreatic
polypeptides, somatostatin, intestinal vasoactive polypeptides;
Disorders of unspecified pancreatic internal secretion:
hyperplasia of the cells of the islets of Langerhans NOS,
hyperplasia of pancreatic islets cells NOS);
D. Diseases of other
endocrine glands – exclude galactorrhea, gynecomastia:
1. Hypoparathyroidism –
excludes Di George syndrome, postprocedural hypoparathyroidism,
NOS tetania, transient neonatal hypoparathyroidism (idiopathic
hypoparathyroidism; Pseudohypoparathyroidism; Other
hypoparathyroidisms; Unspecified hypoparathyroidism –
parathyroid tetania);
2. Hyperparathyroidism
and other disorders of the parathyroid gland – excludes adult,
infantile and juvenile osteomalacia (primary hyperparathyroidism
– parathyroid hyperplasia, generalized fibro-cystic osteitis
(von Recklinghausen bone disease); Secondary hyperparathyroidism
not classified elsewhere – excludes secondary
hyperparathyroidism of renal origin; Other hyperparathyroidisms
– excludes familial hypocalciuric hypercalciuric hypercalcemia;
Unspecified hyperparathyroidism; Other specified disorders of
the parathyroid gland; Unspecified parathyroid gland disorder);
3. Hypersecretion of the
pituitary gland – excludes Cushing's syndrome, Nelson's
syndrome, acth hypersecretion not associated with Cushing's
disease, pituitary ACTH, thyroid stimulating hormone (Acromegaly
and pituitary gigantism: arthropathy associated with acromegaly,
hypersecretion of growth hormone – excludes: constitutional
gigantism, high stature, growth hormone profactor (GHRH);
Hyperprolactinemia; Syndrome of abnormal secretion of
antidiuretic hormone; Other hypersecretions of the pituitary
gland: early central puberty; Hypersecretion of the pituitary
gland);
4. Hyposecretion and other
disorders of the pituitary gland – includes the conditions
presented regardless of whether the disorder occurs in the
pituitary gland or in the hypothalamus and excludes
postprocedural hypopituitarism (Hypopituitarism: the syndrome of
fertile eunuchoidism, hypogonadotrophic hypogonadism, idiopathic
insufficiency of growth hormone, isolated insufficiency of
gonadotrophin, growth hormone, pituitary hormone, Kallmann's
syndrome, Lorain-Levi syndrome, Necrosis of the pituitary gland
(postpartum), Panhypopituitarism, Pituitary(a): caşexia, NOS
insufficiency, statural insufficiency, Sheehan's syndrome,
Simmonds disease; Drug-induced hypopituitarism; Diabetes
insipidus – excludes nephrogenic diabetes insipidus;
Hypothalamic disorders not elsewhere classified – exclude
Prader-Willi syndrome, Russell-Silver syndrome; Other disorders
of the pituitary gland: abscess of the pituitary gland,
adipose-genital dystrophy; Disorders of the pituitary gland
unspecified);
5. Cushing's syndrome
(Pituitary-dependent Cushing's disease: Hypersecretion of
pituitary ACTH, pituitary-dependent hyperadrenocorticism; Nelson
syndrome; Drug-induced Cushing's syndrome; Ectopic secretion
syndrome of ACTH; Alcohol-induced pseudo-cushing syndrome; Other
Cushing syndromes; Unspecified Cushing's syndrome);
6. Adrenogenital disorders
– includes masculinizing or feminizing adrenogenital syndrome,
either acquired or due to adrenal hyperplasia the consequence of
congenital anomalies of hormone synthesis; in women: adrenal
pseudohermaphrodystism, early heterosexual pseudopubertates, in
men: early isosexual pseudopubertates, early mecrogenitosomy,
sexual precocity with adrenal hyperplasia, virilization (in
women) (Congenital adrenogenital disorders related to enzymatic
deficiency: Deficiency of 21-hydroxylase, Congenital adrenal
hyperplasia, Congenital adrenal hyperplasia with salt loss;
Other adrenogeninal disorders; Idiopathic adrenogenital
disorder; Unspecified adrenogenital disorder: ADRENOGENITAL NOS
syndrome);
7. Hyperaldosteronism
(Primary Hyperaldosteronism: Conn syndrome, Primary
Aldosteronism due to adrenal hyperplasia (bilateral); Secondary
hyperaldosteronism; Other hyperaldosteronisms: Bartter's
syndrome; Unspecified hyperaldosteronism);
8. Other adrenocortical
disorders (Other adrenocortical hyperfunctions: Hypersecretion
of ACTH unbound from Cushing's disease, Early adrenocortical
puberty – excludes Cushing's syndrome; Primary adrenocortical
insufficiency: Addison's disease, Autoimmune adrenalitis –
excludes amyloidosis, Addison tuberculous disease,
Waterhouse-Friderichsen syndrome; Addisonian crisis: Adrenal
crisis, Adrenocortical crisis; Primary adrenocortical
insufficiency drug-induced; Adrenocortical insufficiency other
and unspecified – adrenal(a): hemorrhage, infarction;
Adrenocortical insufficiency NOS; Hypoaldosteronism – excludes
adrenal leukodystromy (Addison-Schilder),
Waterhouse-Friderichsen syndrome; Adreno-medullary
hyperfunction: adreno-medullary hyperplasia, hypersecretion of
catecholamine; Other specified disorders of the adrenal gland:
cortisone animal binding globulin; Disorders of the adrenal
gland not specified);
9. Ovarian dysfunction –
excludes the deficiency of the isolate in gonadotrophic,
postprocedural ovarian insufficiency (Hyperestrogenia;
Hypernadrogenia: hypersecretion of ovarian androgens; Polycystic
ovarian syndrome: sclerocystic ovarian syndrome, Stein-Leventhal
syndrome; Primary ovarian failure: estrogen reduction, nose
premature menopause, resistant ovary syndrome – excludes
menopausal disorders and female climaterium, pure gonadal
dysgenesis, Turner syndrome; Other ovarian dysfunctions: OVARIAN
hyperfunction NOS; Unspecified ovarian dysfunction);
10. Testicular
dysfunction – excludes androgen resistance syndrome, azospermia
or oligospermia, isolated insufficiency of gonadotropin,
Klinefelter syndrome, postprocedural testicular hypofunction,
feminized testicle syndrome (Testicular hyperfunction:
hypersecretion of testicular hormones; Testicular hypofunction:
deficiency in 5-alpha-reductase (with male
pseudohermaphroditism), faulty biosynthesis of the testicular
androgenic hormone NOS, nos testicular hypogonadism; Other
testicular dysfunctions; Unspecified testicular dysfunction);
11. Puberty disorders not
elsewhere classified (Delayed puberty: delay of constitutional
development, delayed sexual development; Early puberty:
menstruation – excludes Albright(McCune) syndrome (-Sternberg),
central early puberty, congenital adrenal hyperplasia,
heterosexual pseudopubertatea in women, isosexual
pseudopubertatea in men; Other disorders of puberty: premature
menarche; Unspecified puberty disorders);
12. Pluriglandular
dysfunctions – excludes telangiectatic ataxia (Louis-Bar),
myotonic dystrophy (Steinert), pseudohypoparathyroidism
(Autoimmune polyglandular insufficiency: Schmidt syndrome;
Polyglandular hyperfunction – excludes multiple endocrine
adenomatosis; Other polyglandular dysfunctions; Unspecified
polyglandular dysfunctions);
13. Diseases of the thymus
– excludes aplasia or hypoplasia with immunodeficiency,
myasthenia gravis (Persistent hyperplasia of the thymus:
hypertrophy of the thymus; Abscess of the thymus; Other diseases
of the thymus; Unspecified thymus disease);
14. Other endocrine
disorders – exclude pseudohypoparathyroidism (carcinoid
syndrome; Other hypersecretions of intestinal hormones; Ectopic
hormonal secretion not classified elsewhere; Statural
insufficiency not elsewhere classified – statural insufficiency:
constitutional, Laron type, NOS, psychosocial – excludes
progeria, Russell-Silver syndrome, statural insufficiency:
achindroplazic, hypochondroplastic, l, in congenital
malformation syndrome, in specific dysmorphic syndrome,
nutritional, pituitary, renal, immunodeficiency with micromeal;
High constitutional stature: constitutional gigantism; Androgen
resistance syndrome: male pseudohermaphroditism with androgen
resistance, peripheral hormone receptor disorder, Reifenstein's
syndrome, testicular feminization (syndrome); Other hormonal
disorders specified: pineal gland dysfunction, progeria;
Unspecified endocrine disorder – disorder: endocrine NOS,
hormonal NOS);
15. Endocrine gland
disorders in diseases classified elsewhere (Disorders of the
thyroid gland in diseases classified elsewhere: tuberculosis of
the thyroid gland; Adrenal gland disorders in diseases
classified elsewhere: Waterhouse-Friderichsen syndrome
(meningococcal); Disorders of other endocrine glands in diseases
classified elsewhere);
E. Malnutrition
– the degree of
malnutrition is usually measured in terms of weight, expressed
in the standard deviation from the average of the relevant
reference population; the malnutrition indicator usually occurs
when one or more of the previous measurements are available, the
lack of weight gain in children or the evidence of weight loss
in children or adults; when only one measurement is available,
the diagnosis is based on probabilities and is not definitive
without further clinical or laboratory tests; in exceptional
circumstances where no weight measurement is available, the
diagnosis shall be based on clinical investigations; if a
observed weight is below the mean value of the reference
population, there is a high probability of severe malnutrition
when the observed value is 3 or more standard deviations below
the mean value of the reference population; a high probability
of moderate malnutrition for an observed value is between 2 and
less than 3 standard deviations below this average; and a high
probability of mild malnutrition for an observed value is
localized between 1 and less than 2 standard deviations below
this average – excludes intestinal malabsorption, nutritional
anemias, sequelae of protein-energetic malnutrition, starvation:
1. Kwashiorkor (Severe
malnutrition with nutritional edema with depigmentation of skin
and hair – excludes kwashiorkor from marasm);
2. Nutritional marasm
(severe malnutrition with marasm – excludes kwashiorkor of
marasm);
3. Kwashiorkor de marasm
(serious protein-energy malnutrition: intermediate form, with
signs of both kwashiorkor and marasm);
4. Severe unspecified
protein-energy malnutrition (Severe weight loss (emaceration) in
children or adults, or lack of weight gain in the child,
reaching an observed weight that is at least 3 standard
deviations below the average value for the reference population
(or similar loss expressed according to other statistical
methods), when we have only one measurement, there is a strong
probability of serious smaceration when the weight is 3 or more
standard deviations below the average of the reference
population; Edema of starvation);
5. Mild or moderate
protein-energy malnutrition (Moderate protein-energy
malnutrition: weight loss in children or adults or lack of
weight gain in children resulting in an observed weight of 2 or
more but not exceeding 3 standard deviations below the mean
value for the reference population (or a similar loss expressed
by other statistical approaches); where there is only one
measurement available, there is a high probability of moderate
protein-energy malnutrition when the observed weight is 2 or
more, but not exceeding 3 standard deviations below the
reference population average: Mild protein-energy malnutrition:
Loss of weight in children or adults or lack of weight gain in
children resulting in an observed weight that is 1 or more but
not exceeding 2 standard deviations below the average value for
the reference population (or a similar loss through other
statistical approaches); when only one measurement is available,
there is a high probability of moderate protein-energy
malnutrition when the observed weight is 1 or more, but not
exceeding 2 standard deviations below the average of the
reference population);
6. Developmental delay due
to protein-energetic malnutrition (Nutritional: statural
insufficiency, interruption of growth; Mental retardation due to
malnutrition);
7. Unspecified
protein-energy malnutrition (NOS malnutrition; Nos
protein-energetic imbalance);
F. Other nutritional
deficiencies – exclude nutritional anemia:
1. Avitaminosis A –
exclude sequelae of avitaminosis A (Avitaminosis A with xerosis
of the conjunctiva;
Avitaminosis A with Bitot spots and conjunctiva xerosis: Bitot spots in the small child; Avitaminosis A with corneal xerosis; Avitaminosis A with corneal ulceration and xerosis; Avitaminosis A with keratomalacia; Avitaminosis A with vesperal hemeralopia; Avitaminosis A with xeroftalmic scar of the cornea; Other ocular manifestations of avitaminosis A: NOS xeroftalmia; Other manifestations of avitaminosis A: follicular keratosis due to avitaminosis A, xerodermia due to avitaminosis A; Unspecified A avitaminosis: hypovitaminosis A NOS);
Avitaminosis A with Bitot spots and conjunctiva xerosis: Bitot spots in the small child; Avitaminosis A with corneal xerosis; Avitaminosis A with corneal ulceration and xerosis; Avitaminosis A with keratomalacia; Avitaminosis A with vesperal hemeralopia; Avitaminosis A with xeroftalmic scar of the cornea; Other ocular manifestations of avitaminosis A: NOS xeroftalmia; Other manifestations of avitaminosis A: follicular keratosis due to avitaminosis A, xerodermia due to avitaminosis A; Unspecified A avitaminosis: hypovitaminosis A NOS);
2. Deficiency in thiamine
(vitamin B1) – excludes sequelae of thiamine deficiency
(Beriberi – beriberi: dry, wet; Wernicke encephalopathy; Other
manifestations of deficiency in thiamine; Deficiency in
unspecified thiamine);
3. Deficiency in nicotinic
acid (niacin, vitamin B3) (pellagra) (deficiency in: nicotinic
acid (-tryptophan), nicotinamides; Pellagra (alcoholic) –
excludes sequelae of deficiency in nicotinic acid);
4. Other avitaminosis of
group B – excludes sequelae of avitaminosis B (Anemia by
deficiency of vitamin B12; Deficiency in riboflavins:
ariboflavinosis; Deficiency in pyridoxine: avitaminosis B6 –
excludes sideroblastic anemia reacting to pyridoxine; Deficiency
of other vitamins of group B – deficiency of: biotin,
cyanocobalmin, folate, folic acid, pantothenic acid, vitamin
B12; Avitaminosis of group B not specified);
5. Deficiency of ascorbic
acid – vitamin C deficiency, Scurvy – excludes anemia in scurvy,
sequelae of avitaminosis C;
6. Vitamin D deficiency –
excludes adult osteomalacia, osteoporosis, sequelae of rickets
(Evolutionary rickets – osteomalacia: infantile, juvenile –
excludes rickets: celiac, Crohn, inactive, renal, resistant to
vitamin D; Unspecified vitamin D deficiency: avitaminosis D);
7. Other avitaminosis –
excludes sequelae of other avitaminosis (Vitamin E deficiency;
Vitamin K deficiency – excludes the deficiency of the
coagulation factor due to the deficiency of vitamin K, vitamin K
deficiency of the newborn; Deficiency of other vitamins;
Unspecified avitaminosis);
8. Food deficiency of
calcium – excludes disorders of calcium metabolism, sequelae of
calcium deficiency;
9. Dietary deficiency of
selenium – Keshan disease – excludes sequelae of selenium
deficiency;
10. Zinc deficiency;
11. Deficiency of other
nutritional elements – excludes disorders of the metabolism of
mineral salts, thyroid disorders related to iodine deficiency,
sequelae of malnutrition and other nutritional deficiencies
(Copper deficiency, Iron deficiency – excludes anemia by iron
deficiency; Magnesium deficiency; Manganese deficiency; The
deficiency of chromium; Molybdenum deficiency; Vanadium
deficiency; The deficiency of several specified nutritional
elements; The deficiency of an unspecified nutritional element);
12. Other nutritional
deficiencies – exclude dehydration, developmental insufficiency,
nutritional disorders in the newborn, sequelae of malnutrition
and other nutritional deficiencies (Deficiency of essential
fatty acids; Imbalance of ingested food constituents; Other
specified nutritional deficiencies; Unspecified nutritional
deficiency: NOS nutritional cardiomyopathy);
13. Sequelae of
malnutrition and other nutritional deficiencies (Sequelae of
protein-energy malnutrition – excludes developmental delay as a
result of a protein-energetic malnutrition; Sequelae of
avitaminosis A; Sequelae of avitaminosis C; Sequelae of rickets;
Sequelae of other nutritional deficiencies; Sequelae of
unspecified nutritional deficiencies);
G. Obesity and other
disorders by excess intake:
1. Localized adiposity
(abdominal or protruding sort: adipose burelet);
2. Obesity – excludes
adiposogenital dystrophy, lipomatosis: painful (Dercum), NOS,
Prader-Willi syndrome (Obesity due to a caloric excess;
Drug-induced obesity; Extreme obesity with alveolar
hypoventilation: Pickwickian syndrome; other obesity: morbid
obesity; Unspecified obesity: simple NOS obesity);
3. Other excesses of
intake – exclude hyperection NOS, sequelae of hyperection
(Hyperavitaminosis A; Hypercarontenemia; Hypervitaminosis B6
syndrome; Hypervitaminosis D; Other excesses of the specified
contribution);
4. Sequelae of excess
intake.
H. Metabolism disorders
H. Metabolism disorders
– excludes
5-alpha-reductase deficiency, androgen resistance syndrome,
congenital adrenal hyperplasia, Ehlers-Danlos syndrome,
hemolytic anemia due to enzymatic disorders, Marfan syndrome:
1. Metabolism disorders of
aromatic amino acids (classical Phenylketonuria; Other
hyperphenylalanineemia; Disorders in the metabolism of tyrosine:
Alcaptonuria, Hypertyrosinemia, Occosis, Thynosinemia,
Thynosinosis; Albinism – albinism: ocular, cutaneous-ocular,
Chediak syndrome(-Steinbrinck)-Higashi, Cross, Hermansky-Pudlak;
Other disorders of metabolism of aromatic amino acids –
disorders of: histidine metabolism, tryptophan metabolism;
Disorders of metabolism of unspecified aromatic amino acids);
2. Metabolism disorders
of branched-chain amino acids and fatty acid metabolism
(Maple-smelling urine disease; Other disorders of metabolism of
amino acids but branched chain: Hyperleucine-isoleucinemia,
Hypervalinemia; Isogyrical acidemia; Methylmalonic acidemia;
Propionic acidemia; Metabolism disorders of unspecified
branched-chain amino acids; Disorders of metabolism of fatty
acids: adenoleucodistrophya (Addison-Schilder), insufficiency of
carnitine palmitiltransferase muscle – excludes refsum's
disease, Schilder's disease, Zellweger's syndrome);
3. Other disorders of
amino acid metabolism – exclude abnormal results without obvious
disease, disorders of: aromatic acid metabolism, metabolism of
branched-chain amino acids, fatty acid metabolism, metabolism of
purines and pyrimidines, gout (Disorders in the transport of
amino acids: Cysttinosis, Cistinuria, Fanconi syndrome(-of
Toni)(-Debre), Hartnup's disease, Lowe syndrome – excludes
disorders of tryptophan metabolism; Metabolism disorders of
sulfide amino acids: Cistationinuria, Homocostinuria,
Methioninemia, Deficiency in sulfite oxidase – excludes
transcobalamin II deficiency; Disorders of metabolism of the
urea cycle: Arginemia, Arginosuccinic aciduria, Cytrulinemia,
Hyperamonemia – excludes disorders of ornithine metabolism;
Metabolism disorders of lysine and hydroxylysine: Glutarian
aciduria, Hydroxylysinemia, Hyperlysinemia; Metabolism disorders
of ornithine: ornithinemia; Disorders of glycine metabolism:
Hyperhydroxyprolinemia, Hyperprolinemia, noncetosic
hyperglycinemia, Sarcosinemia; Other specified disorders of
amino acid metabolism – disorders of: beta amino acid
metabolism, gammaglutamil cycle; Metabolism disorders of
unspecified amino acids);
4. Lactose intolerance
(Congenital deficiency in lactase; Secondary deficiency in
lactase; Other lactose intolerances; Intolerance to unspecified
lactose);
5. Other carbohydrate
metabolism disorders – exclude diabetes mellitus, NOS
hypoglycemia, glucagon hypersecretion, mucopolysaccharidosis
(Glycogen storage disease: Cardiac glycogenosis, Disease:
Andersen, Cori, Forbes, Hers, McArdle, Pompe, Bulls, von Gierke,
Deficiency in hepatic phosphorylase; Metabolism disorders of
fructose: Essential fructosuria, Deficiency in
fructose-1,6-diphosphatase, Hereditary fructose intolerance;
Disorders of metabolism of galactose: Galactochinase deficiency,
Galactosemia; Other disorders of intestinal absorption of
carbohydrates: Glucose-galactose malabsorption, Sucrase
deficiency – exclude lactose intolerance; Metabolism disorders
of pyrethrum and gluconeogenesis – Deficiency of: carboxykinase
phosphoenolpyruvate, pyruvat carboxylase, dehydrogenase –
exclude with anemia; Other specified disorders of carbohydrate
metabolism: Essential pentosuria, Oxatosis, Oxaluria, Renal
glycosuria);
6. Metabolism disorders of
spherolipids and other reserve lipids – excludes mucolipidosis
types I-III, Refsum's disease (Gangliosidosis GM2 – disease:
Sandhoff, Tay-Sachs, GANGLIOSIDOSIS GM2 in adult, juvenile, NOS;
Other gangliosidosis – gangliosidosis: GM1, GM3, NOS,
Mucolipidosis IV; Other sphingolipidoses – disease:
Fabry(-Anderson), Gaucher, Krabbe, Niemann-Pick, Farber
syndrome, Metachromatic leukodystrophy, Sulfatase deficiency –
excludes adrenoleukodistrophy (Addison-Schilder); Unspecified
sphthicpidosis; Lipofuscinosis with neuronal ceroid – disease:
Batten, Bielschowsky-Jansky, Kufs, Spielmeyer-Vogt; Other
disorders of reserve lipids: cerebrotendinous cholesterosis (van
Bogaert-Scherer-Epstein), Wolman's disease; Disorders of
unspecified reserve lipids);
7. Disorders of metabolism
of glycosaminoglycans (Mucopolysaccharidosis type I – syndrome:
Hurler, Hurler-Scheie, Scheie; Mucopolysaccharidosis type II:
Hunter's syndrome; Other mucopolysaccharidosis:
Mucopolysaccharidosis type III, IV, VI, VII, Deficiency of
beta-glucoronidase, syndrome: Maroteaux-Lamy (mild) (severe),
Morquio(-similar) (classical), Sanfilippo (type B) (type C)
(type D); Unspecified mocopolysaccharidosis; Other disorders of
glycosaminoglycans metabolism; Metabolism disorders of
unspecified glycosaminoglycans);
8. Disorders of
glycoprotein metabolism (Deficiency of post-translational
transformation of lysosomal enzymes: Mucolipidosis II (disease
of cells I), Mucolipidosis III (polydystrotrophy of pseudo
Hurler; Glycoprotein degradation deficiency:
Aspartilglucosaminuria, Fucosidosis, Manozidosis, Sialidosis
(mucolipidosis I); Other disorders of glycoprotein metabolism;
Unspecified glycoprotein metabolism disorders);
9. Disorders of metabolism
of lipoproteins and other lipidemia – excludes spherolipidosis
(Essential hypercholesterolemia: Familial hypercholesterolemia,
Fredrickson hyperlipoproteinemia type IIa,
Hyperbetalipoproteinemia, Hyperlipidemia group A,
Hyperlipoproteinemia with low density lipoproteins (LDL);
Essential hyperglyceridemia: endogenous hyperglyceridemia,
Fredrickson hyperlipoproteinemia type IV,
Hyperbetalipoproteinemia with very low density lipoproteins
(VLDL); Mixed hyperlipidemia: Broad or floating
betalipoproteinemia, Fredrickson hyperlipoproteinemia type IIb
or III, Hyperbetalipoproteinemia with prebetalipoproteinemia,
Hypercholesterolemia with endogenous hyperglyceridemia,
Hyperlipidemia group C, tubero-eruptive Xanthome, tuberous
Xanthom – excludes cerebrotendinous cholesterosis (van
Bogaert-Scherer-Epstein); Hyperkylomicroanemia: Fredrickson
hyperlipoproteinemia type I or V, Hyperlipidemia group D, Mixed
hyperglyceridemia; Other hyperlipidemia: Combined familial
hyperlipidemia; Unspecified hyperlipidemia; Deficiency in
lipoproteins: Abetalipoproteinemia, Deficiency of high-density
lipoproteins, Hypoalphaloproteinemia, Hypobetalipoproteinemia
(familial), Deficiency of lecithin cholesterol acyltransferase,
Tangier's disease; Other disorders of lipoprotein metabolism;
Disorders of metabolism of unspecified lipoproteins);
10. Metabolism disorders
of purines and pyrimidines – exclude renal lithiasis, combined
immune disorders, gout, anemia with orotaciduria, xeroderma
pigmentosum (Hyperuricemia without signs of inflammatory
arthritis or toface disease: Asymptomatic hyperuricemia;
Lesch-Nyhan syndrome; Other disorders of metabolism of purines
and pyrimidine: hereditary Xanthinuria; Metabolism disorders of
purines and pyrimidines unspecified);
11. Metabolism disorders
of porphyrin and bilirubin – includes deficiency in cantalase
and peroxidase (Hereditary erythropoietic porphyria: Congenital
erythropoietic porphyria, erythropoietic protoporphyria; Late
cutaneous porphyria; Other porphyria: Hereditary coproporphyria
– porphyria: acute periodic (hepatic), NOS; Deficiency in
catalase and peroxidase: Acatalasia (Takahara); Gilbert's
syndrome; Crigler-Najjar syndrome; Other disorders of bilirubin
metabolism: Dubin-Johnson syndrome, Rotor syndrome; Unspecified
bilirubin metabolism disorders);
12. Mineral metabolism
disorders – excludes food deficiency of minerals, parathyroid
gland disorders, vitamin D deficiency (Copper metabolism
disorders: Menkes disease (curly hair) (steely hair), Wilson's
disease; Disorders of iron metabolism: Hemochromatosis –
excludes anemia, iron deficiency, sideroblastic; Zinc metabolism
disorders: Enteropathic acrodermatitis; Disorders of phosphorus
metabolism: Deficiency in acid phosphatase, Familial
hypothalasemia, Hypophosphatase, Resistance to vitamin D
osteomalacia, rickets – excludes adult osteomalacia,
osteoporosis; Metabolism disorders of magnesium:
Hypermagnesemia, Hypomagnesemia, Calcium metabolism disorders:
Familial hypocalciuric hypocalciuria, idiopathic hypercalciuria
– exclude chondrocalcinosis, hyperparathyroidism; Other
disorders of mineral metabolism; Metabolism disorders of
unspecified minerals;
13. Cystic fibrosis –
includes mucoviscidosis (Cystic fibrosis with pulmonary
manifestations; Cystic fibrosis with intestinal manifestations:
Ileus meconial – excludes meconian obstruction in cases where it
is known that cystic fibrosis is not present; Cystic fibrosis
with other manifestations: Cystic fibrosis with combined
manifestations; Unspecified cystic fibrosis);
14. Amyloidosis – excludes
Alzheimer's disease, primary amyloidosis (non-neuropathic
heredofamilial amyloidosis: Mediterranean familial fever,
Hereditary amyloid nephropathy; Neuropathic heredofamilial
amyloidosis: Amyloid polyneuropathy (Portuguese); Unspecified
heredofamilial amyloidosis; Secondary systemic amyloidosis:
Amyloidosis associated with hemodialysis; Amyloidosis in one or
more organs: Localized amyloidosis; Other amyloidosis;
Unspecified amyloidosis);
15. Hypovolemia,
dehydration (Dehydration; Deplection of plasma volume or
extracellular fluid; Hypovolemia – excludes dehydration of the
newborn, hypovolemic shock NOS, postprocedural, traumatic);
16. Other disorders of
acid-base, hydric and electrolyte balance (Hyperosmolarity and
hypernatremia: Excess sodium (Na), Sodium overload (Na) –
excludes diabetes mellitus; Hypoosmolarity and hyponatremia:
Sodium deficiency (Na) – excludes the syndrome of abnormal
secretion of antidiuretic hormone; Acidosis – acidosis: lactic,
metabolic, NOS, respiratory – excludes diabetic acidosis;
Alkalosis – alkalosis: metabolic, NOS, respiratory; Mixed
disorders of acid-base balance; Hyperkalemia: Excess potassium
(K), Potassium overload (K); Hypokalemia: Potassium deficiency
(K); Fluid overload – exclude edema; Other hydric and
electrolyte disorders not elsewhere classified: NOS electrolyte
imbalance, Hyperchloremia, Hypochloremia);
17. Other metabolism
disorders – excludes X histiocytosis (chronic) (Metabolism
disorders of alphaproteins not elsewhere classified:
Alpha-1-antitrypsin deficiency, Bisalbuminemia – excludes
metabolism disorders of lipoproteins, monoclonal gammapathy,
polyclonal hypergammaglobulinemia, Waldenstrom
macroglobulinemia; Lipodystromy unclassified elsewhere:
Lipodystromy NOS – excludes Whipple's disease; Lipomatosis not
classified elsewhere – lipomatosis: painful (Dercum), NOS; Other
disorders of metabolism specified: Defects of the mitochondrial
respiratory canal – Mitochondrial DNA deletion, DEFICIENCY of
NADH-coenzyme Q reductase, NOS, Deficiency of coenzyme
Q-cytochrome reductase, Deficiency of succinate coenzyme Q
reductase, Hoffa-Kastert disease; Launois-Bensaude
adenolipomatosis; Mitochondrial(a): NOS cytopathy, NOS defect,
NOS disease, NOS disorder, NOS syndrome, Trimethyllaminutria;
Unspecified metabolic disorders);
18. Endocrine and
metabolic postprocedural disorders not elsewhere classified
(Postprocedural hypothyroidism: Hypothyroidism after
irradiation; Postprocedural hypoinsulinemia: Hyperglycemia after
pancreatectomy; Postprocedural hypoparathyroidism:
Paratythaoprivous tetania; Postprocedural hypopituitarism:
Hypopituitarism after irradiation; Postprocedural ovarian
failure; Postprocedural testicular hypofunction; Postprocedural
adrenocortical (medullary) hypofunction; Other postprocedural
metabolic and endocrine disorders; Unspecified postproceural
metabolic and endocrine disorders);
Dorin, Merticaru